All posts by: Michael Zand

About Michael Zand

CAR T-Cell Therapy Tops ASCO’s Cancer Advances – MedPage Today

Continue reading

2018-01-30 NEWS

MedPage Today

CAR T-Cell Therapy Tops ASCO’s Cancer Advances
MedPage Today
For its transformative impact on incurable hematologic malignancies, chimeric antigen receptor (CAR) T-cell therapy earned recognition as the Advance of the Year in the American Society of Clinical Oncology (ASCO) Annual Report. Different versions of

and more »

Continue reading

2018-01-30 NEWS

Parkinson’s News Today

Parkinson’s-related Study Identifies Mechanism Underlying Nerve Cell Generation
Parkinson’s News Today
Deleting the enzyme reduced the stem cells‘ ability to proliferate and generate nerve cells, the scientists learned. They also discovered that the m6A modification prevented the stem cells from differentiating into other kinds of precursor cells. The

Continue reading

2018-01-30 NEWS

Breakthrough in Hemophilia Gene Therapy
Medical News Bulletin
As factor IX deficiency stems from an underactive form of the Factor IX gene, hemophilia gene therapy (in which a more active form of the gene is inserted into a patient’s DNA, increasing factor IX production) is being explored as an alternative